Evidence map›Paper›PMID 32886192›Full record

Trial reportDiabetologia2020

Impact of a comprehensive digital health programme on HbA

Melissa McLeod, James Stanley, Virginia Signal, Jeannine Stairmand, Donna Thompson, Kelly Henderson, Cheryl Davies, Jeremy Krebs, Anthony Dowell, Rebecca Grainger and 1 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled TrialEquivalence Trial
PubMed Publisher
In one paragraph

Trial report in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05592288 (The Impact of a Mobile Application Designed for Adults at Risk of Developing Diabetes on Following the Mediterranean Diet Plan, Physical Activity and Metabolic Parameters), which is not on this map. Cited by 18 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05592288 nacompletednot on this mapstarted 2024, after this paper: background citation

The Impact of a Mobile Application Designed for Adults at Risk of Developing Diabetes on Following the Mediterranean Diet Plan, Physical Activity and Metabolic Parameters: a Study Protocol for a Randomized Controlled Trial

TypeinterventionalSponsorAkdeniz UniversityRan2024 to 2024Enrolled61ConditionsDiabetes Mellitus Risk, PreDiabetesArmsPREDIABE-TR mobile app.
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 5 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Melissa McLeodDepartment of Public Health, University of Otago, Wellington, New Zealand. melissa.mcleod@otago.ac.nz.ORCID 0000-0002-5834-7846
James StanleyDepartment of Public Health, University of Otago, Wellington, New Zealand.ORCID 0000-0002-8572-1047
Virginia SignalDepartment of Public Health, University of Otago, Wellington, New Zealand.ORCID 0000-0001-5529-7444
Jeannine StairmandDepartment of Public Health, University of Otago, Wellington, New Zealand.ORCID 0000-0002-1754-902X
Donna ThompsonDepartment of Public Health, University of Otago, Wellington, New Zealand.
Kelly HendersonDepartment of Public Health, University of Otago, Wellington, New Zealand.
Cheryl DaviesKokiri Marae, Seaview, Wellington, New Zealand.
Jeremy KrebsDepartment of Medicine, University of Otago, Wellington, New Zealand.ORCID 0000-0002-7850-3447
Anthony DowellDepartment Primary Health Care and General Practice, University of Otago, Wellington, New Zealand.ORCID 0000-0003-0131-117X
Rebecca GraingerDepartment of Medicine, University of Otago, Wellington, New Zealand.ORCID 0000-0001-9201-8678
Diana SarfatiDepartment of Public Health, University of Otago, Wellington, New Zealand.ORCID 0000-0002-2425-4086
University of Otago · NZMassey University · NZ

Funding

Health Research Council of New Zealand 16/727
6 · The paper itself

Abstract

aims/hypothesisThe aim of this RCT was to evaluate the effectiveness of a digital health programme (BetaMe/Melon) vs usual care in improving the control of type 2 diabetes and prediabetes in a primary care population.

methodsWe conducted a randomised parallel-group two-arm single-blinded superiority trial in the primary care setting in two regions of New Zealand. Eligible participants were identified through Primary Health Organisations and participating practices. Eligibility criteria were as follows: age 18-75 years, HbA

resultsFour hundred and twenty-nine individuals were recruited between 20 June 2017 and 11 May 2018 (n = 215 intervention arm, n = 214 control arm), most of whom were included in analyses of co-primary outcomes (n = 210/215, 97.7% and n = 213/214, 99.5%). HbA CONCLUSIONS/

interpretationThis study did not demonstrate clinical effectiveness for this particular programme. Given their high costs, technology-assisted self-management programmes need to be individually assessed for their effectiveness in improving clinical outcomes for people with diabetes.

trial registrationwww.anzctr.org.au ACTRN12617000549325 (universal trial number U1111-1189-9094)

fundingThis study was funded by the Health Research Council of New Zealand, the Ministry of Health New Zealand and the Healthier Lives National Science Challenge. Graphical abstract.

Indexed as

AdultAgedBody WeightDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansInsulinMaleMiddle AgedPrediabetic StateGlycated HemoglobinInsulinDiabetes mellituseHealthMobile applicationsPrediabetesRandomised controlled trialSelf-management

Identifiers

PMID32886192
OpenAlexW3083332107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.